APC anti-human CD25 clone BC96 and 7 more items

The University of Nebraska Medical Center (UNMC) in Omaha, Nebraska, has awarded a purchase order (PO) #4800154304 to BioLegend Inc., a biological research reagents vendor based in Pasadena, California. The contract, valued at $1,238.30, covers the procurement of eight distinct biological research materials, including specialized antibodies and a recombinant protein. The specific products include APC and FITC-tagged antibodies targeting cellular markers such as CD25, CD62L, CD366 (Tim-3), CD69, CD44, and CD223 (LAG-3), along with a Recombinant Mouse IL-12 (p70).

The contract period spans from October 29, 2025, to November 5, 2025, with delivery to be made F.O.B. destination to UNMC Shipping and Receiving, specifically to the attention of Alyssa Bouska at BCC/SRT 4-1. The purchase is tax-exempt under Nebraska tax exemption #05-8905401, with payment terms set at Net 30. Individual line item prices range from $30.80 to $287.70, reflecting the specialized nature of the scientific research materials being acquired by the university's medical center.